Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? - simplywall.st
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? simplywall.st
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Markets Financial Content
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% Markets Financial Content
Why Thermo Fisher Scientific Stock Jumped 40%? - Trefis
Why Thermo Fisher Scientific Stock Jumped 40%? Trefis
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Yahoo Finance
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% Yahoo Finance
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page